News Articles

Comprehensive vaccine design for commensal disease progression

Abcombi Completes I-Corps at NIH Program for Influenza Indication

   Abcombi representatives completed the February-March

   2017 I-Corps at NIH program in which we refined the

   company’s strategy for our influenza therapeutic.

Abcombi takes home $50,000 in the Critical Path Accelerator Program

   Abcombi took home $50,000 during at the conclusion

   of the Critical Path Accelerator Program

Abcombi selected as a 43North 2016 Finalist

   Abcombi has been announced as a 2016 Finalist for

   the 43North Business Plan Competition.

Abcombi Takes Home the Grand Prize at Bright Buffalo

   Abcombi Biosciences pitched at the Bright Buffalo

   Niagara Entrepreneur Expo and took home the

   grand prize of $20,000.